Letter to the Editor

Notice of Retraction: Gawash A, et al. Association of Body Dysmorphic–Induced Anabolic-Androgenic Steroid Use With Mental Health Outcomes: A Systematic Review. Prim Care Companion CNS Disord. 2023;25(5):23r03532.

December 10, 2024

Mental Health Assessment and Psychosocial Intervention in Maternal-Fetal Interventions

November 18, 2024

In discussing a recent JCP letter to the editor, Akerson et al recommend that centers for fetal diagnosis and treatment include a social worker who can provide psychosocial assessment,...

Valerie M. Akerson, Kara L. Hansen, Kassie Merrill Olver, et al

Letter to the Editor

Clarification Regarding the Psychiatrist’s Role—Reply to Akerson et al

November 18, 2024

The authors respond to a letter by Akerson et al.

Sindhura Vangala, Roy Williams Jr, Cara M. Buskmiller, et al

Letter to the Editor

Is Bariatric Surgery an Antidepressant?

October 29, 2024

The effect of bariatric surgery on mood disorders is uncertain. Read on to find out more.

Ahmed Naguy

Letter to the Editor

Detecting Misuse of Prescription Opioids

October 21, 2024

The authors discuss the difficulty in screening for opioid misuse and the need for clinicians to gain confidence in initiating difficult discussions with patients on long-term opioid treatment.

Vania Modesto-Lowe, Alyssa Crispino, Michael Salley

Letter to the Editor

Harm Reduction in Adolescent Inhalant Use

October 15, 2024

The authors discuss harm reduction efforts targeting inhalant use in the adolescent population.

Vania Modesto-Lowe, Roseane Rodrigues, Deanna Sgambato

Letter to the Editor

Empathy in AI: Insights from Psychodermatology

October 10, 2024

The authors assessed which AI modality has the most potential to help a patient with delusional parasitosis based on the Empathy Scale for Human–Computer Communication score.

Kripa Ahuja, Peter Lio

Letter to the Editor

Smartphone Applications: Therapy at Your Fingertips

August 20, 2024

Dr Modesto-Lowe and colleagues discuss the advancements in smartphone applications for psychiatry, as well as some of the risks.

Vania Modesto-Lowe, Sofia Adams, Amanda Rossi

Letter to the Editor

Zeroing in on Xylazine

August 15, 2024

Dr Kaur and colleagues discuss the need to raise awareness among US public and health care professionals about xylazine due to its infiltration into the illicit drug supply.

Jasleen Kaur, Megan Nosol, Vania Modesto-Lowe

Letter to the Editor

A Mnemonic for Psychiatric History of Presenting Illness

July 18, 2024

In this letter to the editor, Dr Aljeshi presents a mnemonic created to help clinicians obtain a psychiatric history.

Abdulsamad A. Aljeshi

Letter to the Editor

Suicide Attempts in Gambling Disorder

July 4, 2024

Drs Chamberlain and Grant investigate history of suicide attempts among treatment-seeking individuals with gambling disorder who participated in clinical trials in the US.

Samuel R. Chamberlain, Jon E. Grant

Letter to the Editor

Mental Health Assessments for Fetal Interventions

June 24, 2024

The authors offer guidance and raise awareness about the intersection of maternal mental health and fetal interventions.

Letter to the Editor

SSRI-Related Sexual Dysfunction

June 20, 2024

The authors discuss 2 SSRI-related sexual dysfunction syndromes: post-SSRI sexual dysfunction and persistent genital arousal disorder.

Letter to the Editor

Other Nonspecified Feeding or Eating Disorders: Pushing the Envelope

June 18, 2024

The authors shed some light on a wide array of disturbed eating behaviors that defy current nosological and taxonomic boundaries and need further clarification.

Letter to the Editor

Why Ask Patients to Cut Into Quarters 10 mg THC Gummies From a Dispensary When 2.5 mg THC Is Available by Prescription?

June 5, 2024

The authors discuss a study by Sawicki et al of dementia patients for whom 2.5 mg of THC was recommended for neuropsychiatric symptoms.

Marina Goldman, Dimitri Markov

Letter to the Editor

THC Edible Gummies for Behavioral Symptoms of Dementia: Reply to Goldman and Markov

June 5, 2024

The authors reply to Goldman and Markov’s comments on their recent study of dispensary-obtained THC for dementia.

Erin K. Zahradnik, Cristian Hernandez

Letter to the Editor

Intersection of ChatGPT and Reddit

June 4, 2024

The authors discuss the interplay of online social media support groups and interactive chatbots, which may represent a new realm of mental health support.

Kripa Ahuja, Grace DeSena, David Spiegel

Letter to the Editor

Concerns About Long-Term Benzodiazepine Treatment: Reply to Sigler et al

May 27, 2024

Edward Silberman and colleagues respond to a letter about their recent commentary calling for benzodiazepine prescribing guidelines.

Edward Silberman, Antonio E. Nardi, Vladan Starcevic, et al

Letter to the Editor

Psychiatric Disorders and Obstetric Complications

May 27, 2024

Obstetric complications are associated with a higher prevalence of mood and anxiety disorders during the perinatal period.

Marine Jacquelin, Caroline Dubertret, Elodie Gaëlle Ngameni, et al

Letter to the Editor

Evidence-Based Benzodiazepine Practice Guidelines Are Needed

May 27, 2024

The authors discuss a recent commentary by Silberman et al recommending greater guidance in benzodiazepine prescribing.

Breanna Sigler, Bernard Silvernail, Alexis D. Ritvo, et al

Letter to the Editor

An Initiative to Combat Addiction Stigma in Medical Education

May 21, 2024

The authors describe the creation and implementation of a unique online module to address the stigma of addiction in a medical school curriculum.

Zoha Baig, Giselle Appel, Zoe Verzani, et al

Letter to the Editor

What Clinicians Need to Know About Geriatric Depression

May 16, 2024

The authors discuss what clinicians should be aware of when caring for elderly patients with depression.

Ahmed Naguy, Soliman Al-Khadhari

Letter to the Editor

Potential Use of Antidepressants for Long COVID

May 16, 2024

The possibility of repurposing antidepressants as a potential treatment for long COVID first emerged following observations that antidepressants might reduce morbidity and mortality when administered during acute COVID.

Rafael A. Rivas-Vazquez, Enrique J. Carrazana, Emma V. Rivas-Vazquez, et al

Letter to the Editor

Fentanyl Test Strips and Drug Use Modification

May 14, 2024

The authors explore the use of fentanyl test strips as a harm reduction tactic to identify contaminated substances for people who use illicit drugs.

Vania Modesto-Lowe, Robyn Roznitsky, Kiana Caitlin Tan

1 2 3 … 86 »

Letter to the Editor

Notice of Retraction: Gawash A, et al. Association of Body Dysmorphic–Induced Anabolic-Androgenic Steroid Use With Mental Health Outcomes: A Systematic Review. Prim Care Companion CNS Disord. 2023;25(5):23r03532.

Mental Health Assessment and Psychosocial Intervention in Maternal-Fetal Interventions

Clarification Regarding the Psychiatrist’s Role—Reply to Akerson et al

Is Bariatric Surgery an Antidepressant?

Detecting Misuse of Prescription Opioids

Harm Reduction in Adolescent Inhalant Use

Empathy in AI: Insights from Psychodermatology

Smartphone Applications: Therapy at Your Fingertips

Zeroing in on Xylazine

A Mnemonic for Psychiatric History of Presenting Illness

Suicide Attempts in Gambling Disorder

Mental Health Assessments for Fetal Interventions

SSRI-Related Sexual Dysfunction

Other Nonspecified Feeding or Eating Disorders: Pushing the Envelope

Why Ask Patients to Cut Into Quarters 10 mg THC Gummies From a Dispensary When 2.5 mg THC Is Available by Prescription?

THC Edible Gummies for Behavioral Symptoms of Dementia: Reply to Goldman and Markov

Intersection of ChatGPT and Reddit

Concerns About Long-Term Benzodiazepine Treatment: Reply to Sigler et al

Psychiatric Disorders and Obstetric Complications

Evidence-Based Benzodiazepine Practice Guidelines Are Needed

An Initiative to Combat Addiction Stigma in Medical Education

What Clinicians Need to Know About Geriatric Depression

Potential Use of Antidepressants for Long COVID

Fentanyl Test Strips and Drug Use Modification

ELSEWHERE:

FOLLOW US:

Letter to the Editor

Notice of Retraction: Gawash A, et al. Association of Body Dysmorphic–Induced Anabolic-Androgenic Steroid Use With Mental Health Outcomes: A Systematic Review. Prim Care Companion CNS Disord. 2023;25(5):23r03532.

Mental Health Assessment and Psychosocial Intervention in Maternal-Fetal Interventions

Clarification Regarding the Psychiatrist’s Role—Reply to Akerson et al

Is Bariatric Surgery an Antidepressant?

Detecting Misuse of Prescription Opioids

Harm Reduction in Adolescent Inhalant Use

Empathy in AI: Insights from Psychodermatology

Smartphone Applications: Therapy at Your Fingertips

Zeroing in on Xylazine

A Mnemonic for Psychiatric History of Presenting Illness

Suicide Attempts in Gambling Disorder

Mental Health Assessments for Fetal Interventions

SSRI-Related Sexual Dysfunction

Other Nonspecified Feeding or Eating Disorders: Pushing the Envelope

Why Ask Patients to Cut Into Quarters 10 mg THC Gummies From a Dispensary When 2.5 mg THC Is Available by Prescription?

THC Edible Gummies for Behavioral Symptoms of Dementia: Reply to Goldman and Markov

Intersection of ChatGPT and Reddit

Concerns About Long-Term Benzodiazepine Treatment: Reply to Sigler et al

Psychiatric Disorders and Obstetric Complications

Evidence-Based Benzodiazepine Practice Guidelines Are Needed

An Initiative to Combat Addiction Stigma in Medical Education

What Clinicians Need to Know About Geriatric Depression

Potential Use of Antidepressants for Long COVID

Fentanyl Test Strips and Drug Use Modification

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles